Overview
NERR Pharma develops and markets dietary supplements and functional foods. The company is carrying out an EU-funded project on using short-chain fatty acids to treat disorders of the distal colon and plans to expand into medicinal products.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 91 days for 2021).
- 2025not filed
- 202415/07/2025
- 202316/07/2024
- 202214/07/2023
- 202114/10/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Offer
- Dietary supplements
- Functional food
- Dietetic food
- Medicinal products
- Product development
Trademarks
NERR Pharma holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Butiner(word) | Z.498783 | 5, 42 | Protected | Apr 15, 2029 | |
| Nerr Pharma(word) | Z.493496 | 1, 3, 5, 30, 42 | Protected | Dec 5, 2028 |
| Mark | Protected until | |
|---|---|---|
| Butiner(word) | Apr 15, 2029 | |
| Nerr Pharma(word) | Dec 5, 2028 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board is independently authorised to make declarations of will and sign on behalf of the company, whereas in the case of a management board consisting of at least two members, joint action by two members of the management board is required to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mateusz Gawrońskiage 30 | 779 | $21,042.68 | 77.9% |
Grzegorz Paweł Glapaage 58 | 157 | $4,240.95 | 15.7% |
Others | 64 | $1,728.80 | 6.4% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-03-11.
32 1020 1026 0000 1402 0502 6408- 37 1020 1026 0000 1202 0502 6416
- 41 1020 1026 0000 1802 0502 6341
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $419,652.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 26, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,701$2,701 | Prezes Banku Gospodarstwa Krajowego | |
| Sep 16, 2020 | Aid for research and development projects: experimental development | $142.5K$142,498 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 16, 2020 | Aid for research and development projects: industrial research | $114.1K$114,134 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nikalabsp. z o.o. | $3,148,345.23 | nikalab.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Auralab360sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| Wege Siostrysp. z o.o. | $1,339,371.71 | wegesiostry.pl | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| Animal Nutraceuticalssp. z o.o. | $1,056,227.60 | animal-nutraceuticals.pl | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com | ||
| Nexon Pharmasp. z o.o. | $574,250.90 | nexonpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-09-27 | Name change (Axxis Pharma → Nerr Pharma) | |
| 2016-08-05 | Address change (Strusia 8, 91-503, Łódź → Ul. Aleja Fryderyka Chopina 57a, 05-092, Łomianki Dolne) | |
| 2016-08-05 | PKD change (Removed: 51 codes) | |
| 2013-02-08 | Entered in the register |
FAQ
Last updated: 2026-04-25